Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

The impact of pulmonary rehabilitation on activities of daily living in patients with COPD.

Vaes AW, Delbressine JML, Mesquita R, Goertz YMJ, Janssen DJA, Nakken N, Franssen FME, Vanfleteren LEGW, Wouters EFM, Spruit MA.

J Appl Physiol (1985). 2018 Nov 29. doi: 10.1152/japplphysiol.00790.2018. [Epub ahead of print]

PMID:
30496707
2.

Contribution of individual COPD assessment test (CAT) items to CAT total score and effects of pulmonary rehabilitation on CAT scores.

Houben-Wilke S, Janssen DJA, Franssen FME, Vanfleteren LEGW, Wouters EFM, Spruit MA.

Health Qual Life Outcomes. 2018 Oct 30;16(1):205. doi: 10.1186/s12955-018-1034-4.

3.

When the Heart Steals Your Breath Away.

Lahousse L, Vanfleteren LEGW.

Respiration. 2018 Oct 25:1-3. doi: 10.1159/000493760. [Epub ahead of print] No abstract available.

PMID:
30359989
4.

Preview of highlighted presentations from the European Respiratory Society' clinical assembly.

Kahn N, Vanfleteren LEGW, Kaltsakas G, Andrianopoulos V, Gompelmann D, de Jong C, Herth FJF.

J Thorac Dis. 2018 Sep;10(Suppl 25):S3034-S3042. doi: 10.21037/jtd.2018.09.17. No abstract available.

5.

Bronchoscopic Lung Volume Reduction Treatment Using Endobronchial Valves for Emphysema: Emerging Questions.

Hartman JE, Vanfleteren LEGW, van Rikxoort EM, Slebos DJ; on behalf of the SOLVE consortium.

Respiration. 2018;96(6):588-589. doi: 10.1159/000491675. Epub 2018 Oct 4. No abstract available.

6.

The respiratory physiome: Clustering based on a comprehensive lung function assessment in patients with COPD.

Augustin IML, Spruit MA, Houben-Wilke S, Franssen FME, Vanfleteren LEGW, Gaffron S, Janssen DJA, Wouters EFM.

PLoS One. 2018 Sep 12;13(9):e0201593. doi: 10.1371/journal.pone.0201593. eCollection 2018.

7.

CT-derived muscle remodelling after bronchoscopic lung volume reduction in advanced emphysema.

Sanders KJC, Klooster K, Vanfleteren LEGW, Slebos DJ, Schols AMWJ.

Thorax. 2019 Feb;74(2):206-207. doi: 10.1136/thoraxjnl-2018-211931. Epub 2018 Aug 12.

PMID:
30100574
8.

Bronchiectasis Economics: Spend Money to Save Money.

Goeminne PC, Vanfleteren LEGW.

Respiration. 2018;96(5):399-402. doi: 10.1159/000490550. Epub 2018 Jul 24. No abstract available.

PMID:
30041195
9.

Effectiveness of Pulmonary Rehabilitation in Patients With Chronic Obstructive Pulmonary Disease With Different Degrees of Static Lung Hyperinflation.

Vanfleteren MJ, Koopman M, Spruit MA, Pennings HJ, Smeenk F, Pieters W, van den Bergh JJ, Michels AJ, Wouters EF, Groenen MT, Franssen FM, Vanfleteren LE.

Arch Phys Med Rehabil. 2018 Nov;99(11):2279-2286.e3. doi: 10.1016/j.apmr.2018.05.011. Epub 2018 Jun 12.

PMID:
29906421
10.

Looking into the eye of patients with chronic obstructive pulmonary disease: an opportunity for better microvascular profiling of these complex patients.

Vaes AW, Spruit MA, Theunis J, Goswami N, Vanfleteren LE, Franssen FME, Wouters EFM, De Boever P.

Acta Ophthalmol. 2018 Sep;96(6):539-549. doi: 10.1111/aos.13765. Epub 2018 May 16. Review.

PMID:
29770573
11.

Determinants of functional, peak and endurance exercise capacity in people with chronic obstructive pulmonary disease.

McNamara RJ, Houben-Wilke S, Franssen FME, Smid DE, Vanfleteren LEGW, Groenen MTJ, Uszko-Lencer NHMK, Wouters EFM, Alison JA, Spruit MA.

Respir Med. 2018 May;138:81-87. doi: 10.1016/j.rmed.2018.03.032. Epub 2018 Mar 29.

PMID:
29724398
12.

Personalised pulmonary rehabilitation in COPD.

Wouters EFM, Wouters BBREF, Augustin IML, Houben-Wilke S, Vanfleteren LEGW, Franssen FME.

Eur Respir Rev. 2018 Mar 28;27(147). pii: 170125. doi: 10.1183/16000617.0125-2017. Print 2018 Mar 31. Review.

13.

Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future?

Spruit MA, Singh SJ, Rochester CL, Greening NJ, Franssen FME, Pitta F, Troosters T, Nolan C, Vogiatzis I, Clini EM, Man WD, Burtin C, Goldstein RS, Vanfleteren LEGW, Kenn K, Nici L, Janssen DJA, Casaburi R, Shioya T, Garvey C, Carlin BW, ZuWallack RL, Steiner M, Wouters EFM, Puhan MA.

Eur Respir J. 2018 Jan 11;51(1). pii: 1701312. doi: 10.1183/13993003.01312-2017. Print 2018 Jan. No abstract available.

PMID:
29326328
14.

Time for a longer and better life for patients with COPD.

Vanfleteren LEGW, Ullman A, Fabbri LM.

Eur Respir J. 2018 Jan 11;51(1). pii: 1702569. doi: 10.1183/13993003.02569-2017. Print 2018 Jan. No abstract available.

PMID:
29326323
15.

The Fat Lady Sings Again.

Vanfleteren LEGW, Slebos DJ.

Respiration. 2017;94(6):488-490. doi: 10.1159/000481574. Epub 2017 Oct 19. No abstract available.

16.

Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease.

Smid DE, Franssen FME, Gonik M, Miravitlles M, Casanova C, Cosio BG, de Lucas-Ramos P, Marin JM, Martinez C, Mir I, Soriano JB, de Torres JP, Agusti A, Atalay NB, Billington J, Boutou AK, Brighenti-Zogg S, Chaplin E, Coster S, Dodd JW, Dürr S, Fernandez-Villar A, Groenen MTJ, Guimarães M, Hejduk K, Higgins V, Hopkinson NS, Horita N, Houben-Wilke S, Janssen DJA, Jehn M, Joerres R, Karch A, Kelly JL, Kim YI, Kimura H, Koblizek V, Kocks JH, Kon SSC, Kwon N, Ladeira I, Lee SD, Leuppi JD, Locantore N, Lopez-Campos JL, D-C Man W, Maricic L, Mendoza L, Miedinger D, Mihaltan F, Minami S, van der Molen T, Murrells TJ, Nakken N, Nishijima Y, Norman IJ, Novotna B, O'Donnell DE, Ogata Y, Pereira ED, Piercy J, Price D, Pothirat C, Raghavan N, Ringbaek T, Sajkov D, Sigari N, Singh S, Small M, da Silva GF, Tanner RJ, Tsiligianni IG, Tulek B, Tzanakis N, Vanfleteren LEGW, Watz H, Webb KA, Wouters EFM, Xie GG, Yoshikawa M, Spruit MA.

J Am Med Dir Assoc. 2017 Dec 1;18(12):1097.e11-1097.e24. doi: 10.1016/j.jamda.2017.09.003. Review.

17.

The patient with a complex chronic respiratory disease: a specialist of his own life?

Houben-Wilke S, Augustin IM, Wouters BB, Stevens RA, Janssen DJ, Spruit MA, Vanfleteren LE, Franssen FM, Wouters EF.

Expert Rev Respir Med. 2017 Dec;11(12):919-924. doi: 10.1080/17476348.2017.1392242. Epub 2017 Oct 25.

PMID:
29025350
18.

Endothelial function in patients with chronic obstructive pulmonary disease: a systematic review of studies using flow mediated dilatation.

Vaes AW, Spruit MA, Theunis J, Goswami N, Vanfleteren LE, Franssen FME, Wouters EFM, De Boever P.

Expert Rev Respir Med. 2017 Dec;11(12):1021-1031. doi: 10.1080/17476348.2017.1389277. Epub 2017 Oct 12. Review.

PMID:
28978239
19.

Increased exercise tolerance using daytime mouthpiece ventilation for patients with diaphragm paralysis.

Koopman M, Vanfleteren LEGW, Steijns S, Wouters EFM, Sprooten R.

Breathe (Sheff). 2017 Sep;13(3):225-229. doi: 10.1183/20734735.005817.

20.

Altitude and COPD prevalence: analysis of the PREPOCOL-PLATINO-BOLD-EPI-SCAN study.

Horner A, Soriano JB, Puhan MA, Studnicka M, Kaiser B, Vanfleteren LEGW, Gnatiuc L, Burney P, Miravitlles M, García-Rio F, Ancochea J, Menezes AM, Perez-Padilla R, Montes de Oca M, Torres-Duque CA, Caballero A, González-García M, Buist S, Flamm M, Lamprecht B; BOLD Collaborative Research Group; EPI-SCAN Team; PLATINO Team; PREPOCOL Study Group.

Respir Res. 2017 Aug 23;18(1):162. doi: 10.1186/s12931-017-0643-5.

21.

Cognitive impairment and clinical characteristics in patients with chronic obstructive pulmonary disease.

Cleutjens FAHM, Spruit MA, Ponds RWHM, Vanfleteren LEGW, Franssen FME, Gijsen C, Dijkstra JB, Wouters EFM, Janssen DJA.

Chron Respir Dis. 2018 May;15(2):91-102. doi: 10.1177/1479972317709651. Epub 2017 May 29.

22.

The Relationship between Cerebral Small Vessel Disease, Hippocampal Volume and Cognitive Functioning in Patients with COPD: An MRI Study.

Cleutjens FAHM, Ponds RWHM, Spruit MA, Burgmans S, Jacobs HIL, Gronenschild EHBM, Staals J, Franssen FME, Dijkstra JB, Vanfleteren LEGW, Hofman PA, Wouters EFM, Janssen DJA.

Front Aging Neurosci. 2017 Mar 30;9:88. doi: 10.3389/fnagi.2017.00088. eCollection 2017.

23.

Lower-limb muscle function is a determinant of exercise tolerance after lung resection surgery in patients with lung cancer.

Burtin C, Franssen FME, Vanfleteren LEGW, Groenen MTJ, Wouters EFM, Spruit MA.

Respirology. 2017 Aug;22(6):1185-1189. doi: 10.1111/resp.13041. Epub 2017 Mar 30.

PMID:
28370836
24.

[Oxygen therapy not required for all COPD patients].

Vanfleteren LE.

Ned Tijdschr Geneeskd. 2017;161:D1367. Dutch.

PMID:
28351441
25.

Tailoring the approach to multimorbidity in adults with respiratory disease: the NICE guideline.

Vanfleteren LE, Spruit MA, Franssen FM.

Eur Respir J. 2017 Feb 8;49(2). pii: 1601696. doi: 10.1183/13993003.01696-2016. Print 2017 Feb. No abstract available.

26.

The Impact of Cognitive Impairment on Efficacy of Pulmonary Rehabilitation in Patients With COPD.

Cleutjens FAHM, Spruit MA, Ponds RWHM, Vanfleteren LEGW, Franssen FME, Dijkstra JB, Gijsen C, Wouters EFM, Janssen DJA.

J Am Med Dir Assoc. 2017 May 1;18(5):420-426. doi: 10.1016/j.jamda.2016.11.016. Epub 2017 Jan 17.

PMID:
28108209
27.

Domain-specific cognitive impairment in patients with COPD and control subjects.

Cleutjens FA, Franssen FM, Spruit MA, Vanfleteren LE, Gijsen C, Dijkstra JB, Ponds RW, Wouters EF, Janssen DJ.

Int J Chron Obstruct Pulmon Dis. 2016 Dec 19;12:1-11. doi: 10.2147/COPD.S119633. eCollection 2017.

28.

Echocardiographic abnormalities and their impact on health status in patients with COPD referred for pulmonary rehabilitation.

Houben-Wilke S, Spruit MA, Uszko-Lencer NHMK, Otkinska G, Vanfleteren LEGW, Jones PW, Wouters EFM, Franssen FME.

Respirology. 2017 Jul;22(5):928-934. doi: 10.1111/resp.12968. Epub 2016 Dec 21.

PMID:
28001000
29.

Management of chronic obstructive pulmonary disease beyond the lungs.

Vanfleteren LEGW, Spruit MA, Wouters EFM, Franssen FME.

Lancet Respir Med. 2016 Nov;4(11):911-924. doi: 10.1016/S2213-2600(16)00097-7. Epub 2016 Jun 2. Review.

PMID:
27264777
30.

What is the impact of impaired left ventricular ejection fraction in COPD after adjusting for confounders?

Mesquita R, Franssen FM, Houben-Wilke S, Uszko-Lencer NH, Vanfleteren LE, Goërtz YM, Pitta F, Wouters EF, Spruit MA.

Int J Cardiol. 2016 Dec 15;225:365-370. doi: 10.1016/j.ijcard.2016.10.016. Epub 2016 Oct 11.

PMID:
27760413
31.

Determinants of exercise-induced oxygen desaturation including pulmonary emphysema in COPD: Results from the ECLIPSE study.

Andrianopoulos V, Celli BR, Franssen FM, Pinto-Plata VM, Calverley PM, Vanfleteren LE, Vogiatzis I, Vestbo J, Agusti A, Bakke PS, Rennard SI, MacNee W, Tal-Singer R, Yates JC, Wouters EF, Spruit MA.

Respir Med. 2016 Oct;119:87-95. doi: 10.1016/j.rmed.2016.08.023. Epub 2016 Aug 25.

32.

Responsiveness and MCID Estimates for CAT, CCQ, and HADS in Patients With COPD Undergoing Pulmonary Rehabilitation: A Prospective Analysis.

Smid DE, Franssen FM, Houben-Wilke S, Vanfleteren LE, Janssen DJ, Wouters EF, Spruit MA.

J Am Med Dir Assoc. 2017 Jan;18(1):53-58. doi: 10.1016/j.jamda.2016.08.002. Epub 2016 Sep 10.

PMID:
27624705
33.

Indacaterol-Glycopyrronium for COPD.

Franssen FM, Wouters EF, Vanfleteren LE.

N Engl J Med. 2016 Sep 1;375(9):898-9. doi: 10.1056/NEJMc1609305. No abstract available.

PMID:
27579650
34.

Transcutaneous carbon-dioxide partial pressure trends during six-minute walk test in patients with very severe COPD.

Andrianopoulos V, Vanfleteren LE, Jarosch I, Gloeckl R, Schneeberger T, Wouters EF, Spruit MA, Kenn K.

Respir Physiol Neurobiol. 2016 Nov;233:52-59. doi: 10.1016/j.resp.2016.08.003. Epub 2016 Aug 11.

PMID:
27524634
35.

Asymptomatic COPD, until you take it to exertion.

Vanfleteren LE.

Thorax. 2016 Sep;71(9):781-2. doi: 10.1136/thoraxjnl-2016-208863. Epub 2016 Jul 20. No abstract available.

PMID:
27440141
36.

Cardiovascular risk, chronic obstructive pulmonary disease and pulmonary rehabilitation: Can we learn from cardiac rehabilitation?

Triest FJ, Singh SJ, Vanfleteren LE.

Chron Respir Dis. 2016 Aug;13(3):286-94. doi: 10.1177/1479972316642367. Epub 2016 Apr 14. Review.

37.

A new perspective on COPD exacerbations: monitoring impact by measuring physical, psychological and social resilience.

Spruit MA, Franssen FM, Rutten EP, Wopereis S, Wouters EF, Vanfleteren LE.

Eur Respir J. 2016 Apr;47(4):1024-7. doi: 10.1183/13993003.01645-2015. No abstract available.

38.

Changes in structural and metabolic muscle characteristics following exercise-based interventions in patients with COPD: a systematic review.

De Brandt J, Spruit MA, Derave W, Hansen D, Vanfleteren LE, Burtin C.

Expert Rev Respir Med. 2016;10(5):521-45. doi: 10.1586/17476348.2016.1157472. Epub 2016 Apr 6. Review.

PMID:
26901573
39.

Health Status and Morbidities in Resident Relatives of Patients With COPD.

Nakken N, Spruit MA, van den Bogaart EH, van Vliet M, de Vries GJ, Custers FL, Vercoulen JH, Asijee GM, Muris JW, Vanfleteren LE, Franssen FM, Wouters EF, Janssen DJ.

J Am Med Dir Assoc. 2016 Mar 1;17(3):276.e1-8. doi: 10.1016/j.jamda.2015.12.012. Epub 2016 Jan 21.

PMID:
26805754
40.

Body mass index and chronic airflow limitation in a worldwide population-based study.

Vanfleteren LE, Lamprecht B, Studnicka M, Kaiser B, Gnatiuc L, Burney P, Wouters EF, Franssen FM.

Chron Respir Dis. 2016 May;13(2):90-101. doi: 10.1177/1479972315626012. Epub 2016 Jan 14.

41.

Effects of obesity on weight-bearing versus weight-supported exercise testing in patients with COPD.

Maatman RC, Spruit MA, van Melick PP, Peeters JP, Rutten EP, Vanfleteren LE, Wouters EF, Franssen FM.

Respirology. 2016 Apr;21(3):483-8. doi: 10.1111/resp.12700. Epub 2015 Dec 9.

42.

Differential response to pulmonary rehabilitation in COPD: multidimensional profiling.

Spruit MA, Augustin IM, Vanfleteren LE, Janssen DJ, Gaffron S, Pennings HJ, Smeenk F, Pieters W, van den Bergh JJ, Michels AJ, Groenen MT, Rutten EP, Wouters EF, Franssen FM; CIRO+ Rehabilitation Network.

Eur Respir J. 2015 Dec;46(6):1625-35. doi: 10.1183/13993003.00350-2015. Epub 2015 Oct 9.

43.

Poor agreement between chart-based and objectively identified comorbidities of COPD.

Triest FJ, Franssen FM, Spruit MA, Groenen MT, Wouters EF, Vanfleteren LE.

Eur Respir J. 2015 Nov;46(5):1492-5. doi: 10.1183/13993003.00667-2015. Epub 2015 Sep 4. No abstract available.

44.

COPD management: need for more consensus.

Vanfleteren LE, Franssen FM, Wouters EF, Spruit MA.

Lancet Respir Med. 2015 Jul;3(7):e21-2. doi: 10.1016/S2213-2600(15)00192-7. No abstract available.

PMID:
26170079
45.

Prognostic value of variables derived from the six-minute walk test in patients with COPD: Results from the ECLIPSE study.

Andrianopoulos V, Wouters EF, Pinto-Plata VM, Vanfleteren LE, Bakke PS, Franssen FM, Agusti A, MacNee W, Rennard SI, Tal-Singer R, Vogiatzis I, Vestbo J, Celli BR, Spruit MA.

Respir Med. 2015 Sep;109(9):1138-46. doi: 10.1016/j.rmed.2015.06.013. Epub 2015 Jun 25.

46.

Objectively identified comorbidities in COPD: impact on pulmonary rehabilitation outcomes.

Mesquita R, Vanfleteren LE, Franssen FM, Sarv J, Taib Z, Groenen MT, Gaffron S, Bruijnzeel PL, Pitta F, Wouters EF, Spruit MA.

Eur Respir J. 2015 Aug;46(2):545-8. doi: 10.1183/09031936.00026215. Epub 2015 Jun 25. No abstract available.

47.

Various Mechanistic Pathways Representing the Aging Process Are Altered in COPD.

Rutten EP, Gopal P, Wouters EF, Franssen FM, Hageman GJ, Vanfleteren LE, Spruit MA, Reynaert NL.

Chest. 2016 Jan;149(1):53-61. doi: 10.1378/chest.15-0645. Epub 2016 Jan 6.

PMID:
26066545
48.

Determinants of underdiagnosis of COPD in national and international surveys.

Lamprecht B, Soriano JB, Studnicka M, Kaiser B, Vanfleteren LE, Gnatiuc L, Burney P, Miravitlles M, García-Rio F, Akbari K, Ancochea J, Menezes AM, Perez-Padilla R, Montes de Oca M, Torres-Duque CA, Caballero A, González-García M, Buist S; BOLD Collaborative Research Group, the EPI-SCAN Team, the PLATINO Team, and the PREPOCOL Study Group.

Chest. 2015 Oct;148(4):971-985. doi: 10.1378/chest.14-2535.

PMID:
25950276
49.

New insights in chronic obstructive pulmonary disease and comorbidity.

Cleutjens F, Triest F, Wilke S, Vanfleteren LE, Franssen FM, Janssen DJ, Rutten EP, Spruit MA, Wouters EF.

Am J Respir Crit Care Med. 2015 May 1;191(9):1081-2. doi: 10.1164/rccm.201412-2296RR. No abstract available.

PMID:
25932764
50.

Does COPD stand for "COmorbidity with Pulmonary Disease"?

Vanfleteren LE.

Eur Respir J. 2015 Jan;45(1):14-7. doi: 10.1183/09031936.00148014. No abstract available.

Supplemental Content

Loading ...
Support Center